Company Filing History:
1 out of 44 
1 out of 3,923 
1 out of 47 Years Active: 1992-2012
Title: The Innovative Contributions of Stefano Ricci
Introduction
Stefano Ricci is a notable inventor based in Siena, Italy. He has made significant contributions to the field of vaccine analysis, holding a total of 3 patents. His work focuses on improving the quality control of vaccines, particularly those containing capsular saccharides from multiple serogroups.
Latest Patents
One of his latest patents is titled "Analysis of saccharide vaccines without interference." This invention introduces methods that allow for the analysis of mixed meningococcal saccharides from various serogroups, despite their shared monosaccharide units. By combining saccharides from serogroups C, W135, and Y, the invention effectively analyzes the content of sialic acid, glucose, and galactose. The results for glucose and galactose are utilized to quantify saccharides from serogroups Y and W135, respectively. The combined glucose and galactose content is then subtracted from the sialic acid content to determine the quantity of saccharides from serogroup C. This method enables the resolution of the three serogroups, even with overlapping monosaccharide contents. Furthermore, the analysis can be performed on the same material without interference from other saccharide materials, simplifying the quality control process for vaccines.
Another significant patent is "Analysis of liquid chromatography eluates." In this invention, Ricci combines amperometric detection with ultraviolet detection when analyzing saccharides by HPAEC. This dual detection method enhances the information content derived from the analysis, surpassing the capabilities of either detection method used alone.
Career Highlights
Stefano Ricci has worked with prominent companies in the pharmaceutical industry, including Sclavo Spa and Novartis AG. His experience in these organizations has contributed to his expertise in vaccine development and analysis.
Collaborations
Throughout his career, Ricci has collaborated with talented individuals such as Daniela Proietti and Angela Bardotti. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Stefano Ricci's innovative patents and contributions to vaccine analysis demonstrate his commitment to advancing medical science. His work not only enhances the understanding of saccharide vaccines but also improves the quality control processes essential for public health.